Home About Events Press Room Contact Login
IHS Global Insight // Bringing You the Power of Perspective
Healthcare & Pharma Industry Analysis
World Markets Healthcare
World Markets Generics & Biosimilars
World Markets Oncology
World Markets Pricing & Reimbursement
Risk-Sharing Agreement Services
PharmOnline International
Pharma Market Access Custom Solutions
Multi-Client Studies and Market Research
U.S. Healthcare Cost Service

Related Highlights
  IHS Global Insight
Top-10 Economic
Predictions for 2010

  02 Feb 09
Special Report: Generics and Biosimilars—Overview of 2008, Outlook for 2009 and Beyond
  02 Feb 09
Special Report: Pharmaceutical Growth in an Economic Downturn—Wrap-up for 2008, Outlook for 2009


IHS Global Insight's Healthcare and Pharmaceuticals practice provides an independent, comprehensive range of analysis, forecasts, data, and consulting services for:
  • Pharmaceutical manufacturers, wholesalers, and distributors
  • Biotechnology research and development firms
  • Generics manufacturers
  • Healthcare policy makers and regulatory bodies
  • Healthcare providers and insurers
  • Financial institutions and professional services organizations
We can provide you with timely, insightful, and accurate analysis on the evolving regulatory and competitive landscape in more than 60 countries worldwide—enabling you to:
  • Evaluate market opportunities and risks
  • Monitor competitors and customers
  • Assess the impact of a changing regulatory environment
  • Plan and forecast budgets
  • Stay up to date with recent industry developments and market trends
With our unique global perspective and regional expertise, we understand the forces in play—healthcare policy and regulatory developments, world markets pricing & reimbursement, industry-wide corporate strategies, and research and development trends,— and the ways they interact to influence your market opportunities.

Products and Services

IHS Global Insight Healthcare and Pharmaceuticals Experts

Our expert team provides an independent, fact-based view of the healthcare and pharmaceutical industry, fully supported by our 325+ economists and analysts worldwide with expertise in over 120 industries and 200 countries.

IHS Global Insight is the world leader in economic and financial analysis, forecasting, and market intelligence—with more than 40 years' experience and an outstanding record for accuracy.




Perspectives
9 Feb 10
NICE Rejects Three Cancer Drugs from Novartis and BMS


8 Feb 10
CMS Study Indicates Higher Healthcare Public Spending Share by 2019


5 Feb 10
GSK Returns to Sales Growth in 2009 as Strategic R&D Changes are Announced


4 Feb 10
Pfizer Reports 4% Rise in FY 2009, Outlook Estimates Disappoint


More 


Downloads
Healthcare and Pharma Services Overview
Healthcare and Pharma Multi-Client Studies
Pharma Market Access Custom Solutions
Pharma Risk-Sharing Agreement Services
PharmOnline International
World Markets Generics and Biosimilars
World Markets Healthcare
World Markets Oncology
World Markets Pricing & Reimbursement

International Web Site: JapanInternational Web Site: South Africa
 Copyright ©2010 IHS Global Insight Site Map  •  Terms of Use  •  Privacy Policy